Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
NCT00884468
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
Adult Trials: 18+ Years
- Patients both genders over 18 years old
- Patients with PsA diagnosis
- Patients with PsA that suffer from other rheumatologic diseases or non-concomitant
rheumatologic diseases that the investigator considers not to be appropriate for the
study.
- Patients with any medical or physical condition (cognitive damage or difficulties for
understanding) that create difficulties for reading and completing the questionnaires
described in the protocol.
- Patients that in the study period are taking part in another clinical trial.
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Baghdad,
- Metro Manila,
| Descriptive Information | ||||
|---|---|---|---|---|
| Brief Title | Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis | |||
| Official Title | Anxiety and Depression in Patients With Psoriatic Arthritis: Prevalence and Characteristics | |||
| Brief Summary | This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain. | |||
| Detailed Description | Not Provided | |||
| Study Type | Observational | |||
| Study Design | Observational Model: Cohort Time Perspective: Cross-Sectional | |||
| Target Follow-Up Duration | Not Provided | |||
| Biospecimen | Not Provided | |||
| Sampling Method | Probability Sample | |||
| Study Population | Patients with PsA from outpatient's surgery or primary health care centres | |||
| Condition | Psoriatic Arthritis | |||
| Intervention | Not Provided | |||
| Study Groups/Cohorts | 1
Patients with PsA that fulfill the eligibility criteria of the study | |||
| Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
| Recruitment Information | ||||
| Recruitment Status | Completed | |||
| Actual Enrollment | 384 | |||
| Original Actual Enrollment | Same as current | |||
| Actual Study Completion Date | December 2008 | |||
| Actual Primary Completion Date | December 2008 (Final data collection date for primary outcome measure) | |||
| Eligibility Criteria | Inclusion criteria:
Exclusion criteria:
| |||
| Sex/Gender |
| |||
| Ages | 18 Years and older (Adult, Older Adult) | |||
| Accepts Healthy Volunteers | No | |||
| Contacts | Contact information is only displayed when the study is recruiting subjects | |||
| Listed Location Countries | Spain | |||
| Removed Location Countries | ||||
| Administrative Information | ||||
| NCT Number | NCT00884468 | |||
| Other Study ID Numbers | 0881A5-4468 | |||
| Has Data Monitoring Committee | No | |||
| U.S. FDA-regulated Product | Not Provided | |||
| IPD Sharing Statement | Not Provided | |||
| Responsible Party | Wyeth (Registry Contact: Clinical Trial Registry Specialist), Wyeth | |||
| Study Sponsor | Wyeth is now a wholly owned subsidiary of Pfizer | |||
| Collaborators | Not Provided | |||
| Investigators |
| |||
| PRS Account | Wyeth is now a wholly owned subsidiary of Pfizer | |||
| Verification Date | May 2009 | |||